{"count": 2, "results": [{"_id": "8538349", "pmid": 8538349, "title": "Association between angiotensin-converting-enzyme gene polymorphism and failure of renoprotective therapy.", "journal": "Lancet", "authors": ["van Essen GG", "Rensma PL", "de Zeeuw D", "Sluiter WJ", "Scheffer H", "Apperloo AJ", "de Jong PE"], "date": "1996-01-13T00:00:00Z", "doi": "10.1016/s0140-6736(96)90213-5", "meta_date_publication": "1996 Jan 13", "meta_volume": "347", "meta_issue": "8994", "meta_pages": "94-5", "score": 50039.08, "text_hl": "METHODS: 81 @SPECIES_9606 @@@patients@@@ with non-@DISEASE_Diabetic_Nephropathies @DISEASE_MESH:D003928 @@@diabetic renal disease@@@ had been entered into a randomised comparison of oral @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ or @CHEMICAL_Enalapril @CHEMICAL_MESH:D004656 @@@enalapril@@@ to prevent progressive @<m>DISEASE_Cognitive_Dysfunction</m> @DISEASE_MESH:D060825 @@@decline in renal function@@@. ", "citations": {"NLM": "van Essen GG, Rensma PL, de Zeeuw D, Sluiter WJ, Scheffer H, Apperloo AJ, de Jong PE. Association between angiotensin-converting-enzyme gene polymorphism and failure of renoprotective therapy. Lancet. 1996 Jan 13;347(8994):94-5. PMID: 8538349", "BibTeX": "@article{8538349, title={Association between angiotensin-converting-enzyme gene polymorphism and failure of renoprotective therapy.}, author={van Essen GG and Rensma PL and de Zeeuw D and Sluiter WJ and Scheffer H and Apperloo AJ and de Jong PE}, journal={Lancet}, volume={347}, number={8994}, pages={94-5}}"}}, {"_id": "8889352", "pmid": 8889352, "title": "Appointment attendance, pill counts, and achievement of goal blood pressure in the African American Study of Kidney Disease and Hypertension Pilot Study.", "journal": "Control Clin Trials", "authors": ["Lee JY", "Greene PG", "Douglas M", "Grim C", "Kirk KA", "Kusek JW", "Milligan S", "Smith DE", "Whelton PK"], "date": "1996-08-01T00:00:00Z", "doi": "10.1016/s0197-2456(97)82680-3", "meta_date_publication": "1996 Aug", "meta_volume": "17", "meta_issue": "4 Suppl", "meta_pages": "34S-39S", "score": 50035.934, "text_hl": "The African American Study of @DISEASE_Kidney_Diseases @DISEASE_MESH:D007674 @@@Kidney Disease@@@ and @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@Hypertension@@@ (AASK) Pilot Study evaluated the feasibility of conducting a 7-year clinical trial to assess the effect of two levels of blood pressure control based on mean arterial pressure (MAP) (low goal < or = 92 mm Hg or usual goal of 102-107 mm Hg) and three antihypertensive drug regimens (@<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@, @CHEMICAL_Amlodipine @CHEMICAL_MESH:D017311 @@@amlodipine@@@, or @CHEMICAL_Enalapril @CHEMICAL_MESH:D004656 @@@enalapril@@@) as initial therapy in slowing the @<m>DISEASE_Cognitive_Dysfunction</m> @DISEASE_MESH:D060825 @@@decline of renal function@@@ in African Americans with clinically diagnosed @DISEASE_Nephrosclerosis @DISEASE_MESH:D009400 @@@hypertensive nephrosclerosis@@@. ", "citations": {"NLM": "Lee JY, Greene PG, Douglas M, Grim C, Kirk KA, Kusek JW, Milligan S, Smith DE, Whelton PK. Appointment attendance, pill counts, and achievement of goal blood pressure in the African American Study of Kidney Disease and Hypertension Pilot Study. Control Clin Trials. 1996 Aug;17(4 Suppl):34S-39S. PMID: 8889352", "BibTeX": "@article{8889352, title={Appointment attendance, pill counts, and achievement of goal blood pressure in the African American Study of Kidney Disease and Hypertension Pilot Study.}, author={Lee JY and Greene PG and Douglas M and Grim C and Kirk KA and Kusek JW and Milligan S and Smith DE and Whelton PK}, journal={Control Clin Trials}, volume={17}, number={4 Suppl}, pages={34S-39S}}"}}]}